HIF (hypoxia-inducible factor)-3α is the third member of the HIF transcription factor family. Whereas HIF-1α and -2α play critical roles in the cellular and systemic adaptation to hypoxia, little is known about the regulation and function of HIF-3α. At least five different splice variants may be expressed from the human HIF-3α locus that are suggested to exert primarily negative regulatory effects on hypoxic gene induction. In the present paper, we report that hypoxia induces the human HIF-3α gene at the transcriptional level in a HIF-1-dependent manner. HIF-3α2 and HIF-3α4 transcripts, the HIF-3α splice variants expressed in Caki-1 renal carcinoma cells, rapidly increased after exposure to hypoxia or chemical hypoxia mimetics. siRNA (small interfering RNA)-mediated HIF-α knockdown demonstrated that HIF-3α is a specific target gene of HIF-1α, but is not affected by HIF-2α knockdown. In contrast with HIF-1α and HIF-2α, HIF-3α is not regulated at the level of protein stability. HIF-3α protein could be detected under normoxia in the cytoplasm and nuclei, but increased under hypoxic conditions. Promoter analyses and chromatin immunoprecipitation experiments localized a functional hypoxia-responsive element 5 to the transcriptional start of HIF-3α2. siRNA-mediated knockdown of HIF-3α increased transactivation of a HIF-driven reporter construct and mRNA expression of lysyl oxidase. Immunohistochemistry revealed an overlap of HIF-1α-positive and HIF-3α-positive areas in human renal cell carcinomas. These findings shed light on a novel aspect of HIF-3α as a HIF-1 target gene and point to a possible role as a modulator of hypoxic gene induction.
INTRODUCTION
Of the three hypoxia-inducible transcription factor family members identified in mammals so far, HIF (hypoxia-inducible factor)-3 is the least characterized and understood. HIF-1 and -2 are heterodimeric transcription factors that mediate the systemic and cellular response to hypoxia and consist of two bHLH (basic helix-loop-helix) PAS (Per/Arnt/Sim)-domain proteins, of which the α-subunit is oxygen-regulated and the β-subunit constitutively expressed (for a review, see [1] ). HIF-β is identical with the ARNT (aryl hydrocarbon receptor nuclear translocator) and thus is also part of transcription-factor complexes involved in the xenobiotic response [2] . Two of the alternative α-subunits, HIF-1α and HIF-2α, transactivate many functionally heterogeneous genes involved, for example, in anaerobic glucose metabolism, erythropoiesis and angiogenesis.
HIF-1α and HIF-2α show significant structural homology and are primarily regulated at the protein level by oxygen-dependent destabilization, which is preceded by enzymatic hydroxylation of two conserved proline residues in their oxygen-dependent degradation domains. At least three PHD (prolyl hydroxylase domain) proteins (PHD1-3) have been identified that modify the HIF-α subunits using dioxygen and 2-oxoglutarate as cosubstrates. This modification enables binding of pVHL (von Hippel-Lindau tumour suppressor protein), which targets the HIF-α subunits for proteasomal degradation. Under hypoxia, the HIF-α subunits are thus stabilized, dimerize with HIF-β, translocate to the nucleus and transactivate their target genes. In addition to regulation of protein stability, the activity of HIF-1α is repressed in an oxygen-dependent manner by FIH-1 (asparagyl hydroxylase factor inhibiting HIF-1) (for a review, see [1] ). The vast majority of HIF target genes are regulated by HIF-1α, whereas exclusively HIF-2α-dependent genes are scarce and celltype-dependent [3] [4] [5] [6] .
In 1998, a third HIF-α isoform was identified which exhibits ∼ 55 % amino acid sequence identity with HIF-1α and HIF-2α in its bHLH PAS domain [7] . It also contained an ODD (oxygen-dependent degradation domain) and an NTAD (Nterminal transactivation domain), similar to HIF-1α and HIF-2α, but no CTAD (C-terminal transactivation domain). In 2001, murine IPAS (inhibitory PAS domain protein) was shown to be a repressor of HIF-dependent gene induction by virtue of its ability to bind to HIF-1α [8] . Subsequently, IPAS was demonstrated to be a splice variant originating from the murine HIF-3α locus. Highly expressed in the mouse brain and eye, hypoxic IPAS induction impairs up-regulation of VEGF (vascular endothelial growth factor) activity in the avascular cornea during sleep and thereby prevents angiogenesis [8] . Interestingly IPAS, but not HIF-3α, is up-regulated under hypoxia by differential splicing and transcriptional induction [9, 10] .
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The human HIF-3α locus may give rise to at least five alternatively spliced transcripts, of which three (HIF-3α1-3) contain the ODD and NTAD, but differ in their C-terminal and Nterminal ends, whereas the other splice variants lack the complete C-terminal half of the protein, including the ODD and NTAD [11] . Moreover, HIF-3α1-3 differ by alternative first exons, resulting in different translational start sites. HIF-3α2 thereby lacks most of the DNA-binding bHLH domain. Functional discrimination of the HIF-3α splice variants are impaired by the lack of cell lines expressing HIF-3α at high levels and of isoform-specific antibodies.
Interestingly, the human IPAS orthologue HIF-3α4 was detected in the kidney and shown to be reduced in RCCs (renal cell carcinomas) [12] . Since its down-regulation may enhance hypoxic gene induction in kidney tumours, this effect may contribute to tumorigenesis [12] .
To gain insight into the function and regulation of HIF-3α, we screened a number of cell types and identified renal carcinoma Caki-1 cells as a cell line with high HIF-3α expression. We found that hypoxia induces different HIF-3α splice variants at the transcriptional level, mediated by HIF-1α, and that HIF-3α may exert a modulating effect on specific HIF target genes.
EXPERIMENTAL

Cell culture
Caki-1 renal carcinoma cells, Hep3B and HepG2 hepatoma cells, HeLa cervical cancer cells, Kelly neuroblastoma, HT1080 fibrosarcoma and HEK-293 human embryonic kidney cells were purchased from the A.T.C.C. or the DSMZ (Braunschweig, Germany). The pVHL-deficient and -reconstituted (+VHL) RCC cell lines 786-0 and RCC4 were provided by P. Ratcliffe (Centre for Cellular and Molecular Physiology, University of Oxford, Oxford, U.K.) and P. Maxwell (Rayne Institute, University College London, London, U.K.), and HKC-8 renal tubular cells by L. Racusen (Department of Pathology, John Hopkins University School of Medicine, Baltimore, MD, U.S.A.). Carcinoma cells were grown in Dulbecco's modified Eagle's medium, 1.0 g glucose/l, 10 % (v/v) fetal bovine serum and antibiotics (100 i.u. of penicillin and 100 μg/ml streptomycin). hPT (human primary renal tubular epithelial) cells were prepared from tumour nephrectomies and cultured as described previously in [13] . Hypoxic stimulation was accomplished by exposing cells to 1 % oxygen in a Jouan IG750 incubator (Thermo Electron). For chemical HIF induction, the iron chelator DP (2,2 -dipyridyl; 100 μM) and the iron-independent hydroxylase inhibitor DMOG (dimethyloxalylglycine; 1 mM) were used.
RPA (RNase protection assay)
Templates for RNA probes were generated by RT-PCR (reverse transcription PCR) using the primers listed in Supplementary  Table S1 at http://www.BiochemJ.org/bj/424/bj4240143add.htm. Amplified fragments were cloned into the pSP72 vector (Promega).
32 P-labelled RNA probes were generated by in vitro transcription and RPAs were carried out as described in [3, 14] . Quantification of signals was performed using a Phosphoimager (Fuji BAS 2000) and AIDA ® image analysis software (Raytest).
RT-PCR
RNA was transcribed using random hexamer primers and M-MuLV Reverse Transcriptase (MBI Fermentas). For the differentiation of HIF-3α splice variants, PCR reactions were carried out with isoform-specific primers (Supplementary Table   S1 ) and analysed on 2 % agarose gels. For quantification, realtime PCR was performed on an ABI-Prism7000 thermocycler with SYBR Green Master Mix (Applied Biosystems). Data were analysed using the 2 (− Ct ) method. Relative expression levels were calculated using β-actin mRNA as a reference. Primers are listed in Supplementary Table S1 .
SiRNA transfections
Cells were transfected with HIF-1α and HIF-2α siRNAs at 50 nM as described previously in [3, 14] . SiRNAs directed against luc (luciferase) and GFP (green fluorescent protein) were used as controls. For HIF-3α knockdown, normal siRNAs (HIF-3α and HIF-3α ; Qiagen and Eurogentec) and stabilized Stealth ® siRNAs (3α69 and 3α70; Invitrogen) and a GC content-matched Stealth ® control siRNA (H; Invitrogen) were used (see Table S1 ). All HIF-3α siRNAs were targeted to HIF-3α1-4.
Promoter constructs and luciferase reporter assays
Candidate HREs (hypoxia-responsive elements) in the HIF-3α genomic locus were localized using MatInspector ® software (Genomatix) [15] . DNA fragments comprising the HREs were PCR-amplified and cloned into pGL2-Basic vector (Promega). The functional HRE was inactivated by site-directed mutagenesis using PCR, with the overlapping HRE mutagenesis primers given in Supplementary Table S1 as inner primers and the prom seq.2 primers as outer primers. Luciferase reporter assays were carried out as described in [3] . The functional role of HIF-3α was investigated by co-transfection of HIF-3α siRNAs with a 6 × HRE luciferase reporter (6 × HRE-luc). Owing to the long half-life of HIF-3α protein, cells were stimulated 32 h after transfection for a further 16 h.
ChIP (chromatin immunoprecipitation)
Binding of HIF-1 to the candidate HREs of the HIF-3α gene was demonstrated by ChIP analyses as described previously [16] . Cells were fixed with 1 % (v/v) formaldehyde, lysed with 1 % (w/v) SDS and sonicated for 3 cycles of continuous 10 s treatment, with 30 % output. Samples were then diluted 10-fold, divided into two parts, and precipitated with 1 μg of anti-HIF-1α rabbit polyclonal antibody (NB 100-449; Novus Biologicals) or normal rabbit serum and Protein A agarose (Roche). Precipitated DNA was used for PCR with the primers listed in Supplementary  Table S1 .
Immunoblotting
Protein expression of HIF-α subunits was analysed as described in [3, 14] with polyclonal anti-HIF-3α (ab10134; Abcam; diluted 1:2500), anti-HIF-1α (NB100-449; Novus Biologicals; diluted 1:1000) or anti-HIF-2α (NB100-122; Novus Biologicals; diluted 1:1000) antibodies; anti-β-actin antibody (monoclonal antibody AC-74; Sigma) was used as a loading control. X-ray films were scanned and signals quantified densitometrically using the AIDA ® software.
Tumour collection
Tissue specimens were collected from total nephrectomy in patients with renal clear-cell carcinoma [17] . All patients gave their informed consent. The work was carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association and was approved by local Ethics Committees. Immediately after surgical removal, tissue samples were snapfrozen or fixed overnight in 4 % (w/v) paraformaldehyde. 
Immunohistochemistry
HIF-3α and HIF-1α protein were immunostained in human kidney tumour sections as described in [17] . For immunofluorescence, Alexa Fluor ® 488-labelled secondary antibodies were used.
Statistical analysis
Data are expressed as mean + − S.D. or mean + − S.E.M., as appropriate. Statistical analyses were carried out using StatView software (version 5.0; SAS Institute, Inc.). Comparisons among groups were made using ANOVA, with the correction of Bonferroni-Dunn's method, where applicable. P values of <0.05 were considered significant.
RESULTS
Expression and hypoxic induction of HIF-3α splice variants in Caki-1 cells
First we screened human cell lines for HIF-3α expression by RPA using a probe for the PAS-B domain of HIF-3α, which is contained in all splice variants ( Figure 1A) . Among ten cell lines tested, Caki-1 renal carcinoma cells expressed HIF-3α mRNA at the highest level by far, showing a moderate increase after stimulation with the hypoxia mimetic DP ( Figure 1B ). Hep3B and HeLa cells expressed about 10 % of HIF-3α transcript levels found in Caki-1 cells. In VHL-deficient and VHL-reconstituted 786-0 and RCC4 renal carcinoma cells, HIF-3α was not detectable by RPA or RT-PCR ( Figure 1B ; results not shown for RCC4). Therefore we used primarily Caki-1 cells for subsequent experiments. Hypoxia
(1 % O 2 ) and the hypoxia mimetics DP and DMOG stimulated HIF-3α mRNA expression ∼ 3-fold as determined by RPA (hypoxia 3.0 + − 0.9-fold, DP 3.9 + − 0.7-fold and DMOG 3.6 + − 0.3-fold; P < 0.05 for each treatment compared with control, n = 3-4; Figure 1C ). Five splice variants have been reported and confirmed for the human HIF-3α locus ( Figure 1A ). The ODDcontaining transcripts for HIF-3α1, 2 and 3 differ structurally in terms of their transcriptional start sites, thus allowing further differentiation. RT-PCR analyses identified a specific band for HIF-3α2, whereas those corresponding to HIF-3α1 and 3 were absent for amplifications of up to 40 cycles ( Figure 1D ). HIF-3α6 was also absent (results not shown).
Next we quantified mRNA levels of the HIF-3α splice variants by RPA using two different probes directed against the ODD (for HIF-3α1, 2 and 3) and HIF-3α4 respectively ( Figures 1A and 1E ). After 4 h and 16 h of hypoxia, HIF-3αODD-containing transcripts (in the present study, HIF-3α2) and HIF-3α4 were clearly increased, reaching 2.2 + − 0.2-fold and 2.8 + − 0.4-fold respectively (P < 0.05 for both treatments compared with unstimulated controls, n = 3; Figure 1F ). Although total HIF-3α expression was markedly lower, a similar induction was observed in Hep3B cells (results not shown). In addition, qRT-PCR (quantitative real-time PCR) analysis identified HIF-3α transcripts in hPT cells (passage numbers 1-3) and in RNA samples from human normal kidney tissue obtained from tumour nephrectomies. In hPT cells, total HIF-3α mRNA expression was induced significantly by hypoxia and DP, suggesting that HIF-3α is expressed in tubular cells under physiological conditions and that its hypoxic induction may also be preserved in the kidney ( Figure 1G ). 
Hypoxic induction of HIF-3α requires HIF-1α
A time-course analysis of HIF-3α mRNA induction following DP-stimulation revealed kinetics similar to those of known HIF-1 target genes such as ANGPTL4 (angiopoietin-like 4) [18] ( Figure 2A ). Therefore we hypothesized that HIF-3α might be a direct transcriptional target of HIF-1 and examined the effects of siRNAs directed against HIF-1α and HIF-2α on HIF-3α mRNA expression. Knockdown of HIF-1α, but not of HIF-2α, significantly reduced the induction of ODD-containing transcripts and HIF-3α4 (both P < 0.01 compared with DPstimulated controls), indicating that HIF-3α requires HIF-1α for transcriptional up-regulation ( Figure 2B ). HIF-α immunoblotting confirmed the efficiency of the HIF-α knockdown ( Figure 2C ). To address the possibility that HIF-1 might indirectly increase HIF-3α mRNA levels through the induction of a mediator, we investigated the effect of HIF-α knockdown after short-term stimulation. After 4 h of DP-stimulation, HIF-1α knockdown had already reduced the stimulated mRNA levels of both splice variants by ∼ 30 %, and after 8 h by 40% (n = 3), suggesting that HIF-3α may be a direct target of HIF-1 ( Figure 2D ). In unstimulated normoxic Caki-1 cells, i.e. in the absence of HIF-1α protein, HIF-1α siRNA transfection did not reduce HIF-3α mRNA expression, as determined by the use of qRT-PCR for reasons of sensitivity ( Figure 2E ).
HIF-1α binds to regulatory elements in the human HIF-3α gene
Next we searched the HIF-3α genomic locus for consensus (R)CGTG/C HIF-binding motifs by the use of the MatInspector ® software (Genomatix; [15] ). Screening 20 kbp of the 5 -flanking region up to exon 2, we identified six candidate HIF-binding sites ( Figure 3A and Supplementary Table S2 at http://www.BiochemJ.org/bj/424/bj4240143add.htm). We then determined whether HIF-1 binds to these sequences using ChIP assays. Of three sets of PCR primers used, primer pair 2 yielded an amplified fragment when hypoxic cell lysates were immunoprecipitated with an anti-HIF-1α antibody, which indicated that HIF-1 binds to the HRE at nucleotides 42496-42508 (termed 'c' in Figure 3A ) in the HIF-3α gene ( Figure 3B ).
Hypoxic regulation of HIF-3α promoter constructs
The functionality of this HIF-binding motif was corroborated in luciferase reporter assays. We cloned three different HIF-3α promoter fragments into pGL2-Basic vector to cover all candidate HREs and examined their hypoxic induction in different cell types ( Figures 3A and 3C) . Following DP-stimulation in Hep3B cells, luciferase activity of the reporter driven by the HIF-3α promoter fragment nucleotides 42365-43656 (seq.2-luc) increased 2.9-fold, whereas all other reporter constructs retained activation levels similar to that of the pGL2 control vector (1.8-1.9-fold). Identical results were obtained by co-transfection of a normoxically stable HIF-1α triple mutant (mHIF-1αTM) in HEK-293 cells. Again, the seq.2-luc reporter responded more markedly than the other constructs including pGL2 control (16.9-fold compared with 5.0-5.6-fold), suggesting that the seq.2 fragment contains a functional HIF-binding motif. Thus motif 'c' was considered to play a critical role for the hypoxic induction of HIF-3α mRNA. The region spanning nucleotides 42365-43656 (seq.2) was therefore characterized further. A 3 -terminal deletion of this promoter fragment from nucleotide 42741 (seq.22) to nucleotide 42484 (seq.23) blunted the hypoxic induction markedly (2.6 + − 0.5-fold compared with 1.5 + − 0.1-fold, P < 0.01; Figure 3D ). In contrast, deleting the 5 -end from nucleotide 42365 (seq.22) to nucleotide 42484 (seq.25) did not affect the hypoxic response significantly (2.6 + − 0.5 compared with 2.3 + − 0.3-fold; P not significant), which suggested that a functional hypoxiaresponsive sequence was located between nucleotides 42484 and 42741. Mutagenesis of the HRE candidate motif 'c' at nucleotides 42496-42508 from ACGTC to AGATC (seq.2mut) markedly reduced the hypoxic activation (3.0 + − 0.5 compared with 1.8 + − 0.3-fold, P < 0.01; Figure 3D ). These results further supported the hypothesis that the HRE at nucleotides 42496-42508 upstream of exon 1b is critical for the hypoxic induction of the HIF-3α promoter.
Expression and subcellular localization of HIF-3α protein
The anti-HIF-3α antibody used in the present study was raised against a peptide within the 300-400-amino-acid region of HIF-3α and therefore predicted not to detect HIF-3α4. Thus the band of ∼ 60 kDa that was marked by the antibody in Caki-1 cells was considered to represent HIF-3α2 according to the results of the RNA analyses. In some experiments, at longer exposure times, a second, slower-migrating band appeared, which may represent a different splice variant or modified HIF-3α2. In keeping with this notion, pre-incubation of the antibody solution with the HIF-3α peptide used for immunization eliminated both bands in immunoblot assays (results not shown).
Hypoxic induction of HIF-3α was also observed at the protein level, albeit less strikingly than at the transcript level. In Caki-1 cells, hypoxia induced HIF-3α protein 1.5 + − 0.2-fold and DP induced HIF-3α 1.2 + − 0.09-fold (P < 0.05, n = 4; Figure 4A ). The differences between normoxic and stimulated cells may have been underestimated, owing to the method of quantification (scanning and densitometric analysis of X-ray films). In accordance with mRNA data, Caki-1 cells expressed HIF-3α protein more abundantly than did HeLa cells. HIF-3α protein was also detectable in hPT cells (results not shown). When 200 μg of protein were loaded, three hypoxia-inducible bands were demarcated by the antiserum.
In contrast with HIF-1α, HIF-3α did not accumulate during 2 h of DP-stimulation, which indicates that HIF-1α, but not HIF-3α, is subject to oxygen-dependent protein destabilization, which is rapidly inhibited by DP ( Figure 4B ). Translational inhibition by cycloheximide revealed that HIF-3α has a distinctly longer protein half-life (∼ 18 h) in Caki-1 cells compared with HIF-1α, indicating that these two HIF-α family members are regulated by different molecular mechanisms ( Figure 4C) . As observed at the mRNA level, siRNA-mediated knockdown of HIF-1α, but not HIF-2α, again notably offset the DPstimulated increase in HIF-3α protein ( Figure 4D ; for HIF-2α protein knockdown, see Figure 2C ), which confirmed that HIF-3α induction requires HIF-1α activation. HIF-1α knockdown reduced hypoxic HIF-3α protein expression by 32 + − 17 % (P < 0.05, n = 4), whereas HIF-2α knockdown had no significant effect (102 + − 13 % of luc-siRNA-transfected DPstimulated cells).
Immunofluorescence analysis was performed to determine the subcellular localization of HIF-3α in Caki-1 cells ( Figure 4E ). HIF-3α was found in both cytoplasm and nuclei under normoxia. Overnight exposure to hypoxia or DP enhanced, in particular, the nuclear signals as determined by co-staining of the nuclei with Hoechst dye.
Effect of siRNA-mediated HIF-3α knockdown on HIF-1α activity HIF-3α has been proposed to serve as a competitive inhibitor of other HIFs, notably HIF-1α. Therefore we examined the effect of HIF-3α knockdown on HIF-1-driven reporter-gene induction in Caki-1 and Hep3B cells. Probably owing to the long half-life of HIF-3α protein, knockdown proved to be difficult. The first siRNA (HIF-3α ) reduced HIF-3α protein levels by 12-16 % after 48 h and the second (HIF-3α ) by ∼ 50 % in both Caki-1 and Hep3B cells, whereas the expression of HIF-1α protein was not affected (Figures 5A and 5B) . In Hep3B cells, co-transfection of siRNA HIF-3α with a 6 × HRE-luc reporter significantly increased DP-stimulated reporter activity in comparison with GFP-controlsiRNA-transfected, DP-stimulated cells ( Figure 5C ). The siRNA HIF-3α had no significant effect. We tried to improve knockdown efficiency with chemically stabilized Stealth ® siRNAs. SiRNAs 3α69 and 3α70 did not significantly alter HIF-1α or HIF-2α protein induction ( Figure 5D ). SiRNA 3α69 reduced DP-stimulated HIF-3αODD transcript levels in Caki-1 cells to 66 + − 13 % and HIF-3α4 transcript levels to 71 + − 3 %, siRNA 3α70 HIF-3αODD mRNA to 32 + − 5 % and HIF-3α4 mRNA to 50 + − 11 % compared with control siRNA H as determined by RPA (n = 3; Figure 5E ). Using the more sensitive qRT-PCR analysis, total HIF-3α knockdown amounted to 18 % of DP-stimulated control values by the 3α69 siRNA and 7 % by the 3α70 siRNA respectively ( Figure 5E, histogram) . HIF-2α mRNA expression was reduced to 72 + − 5 % (P < 0.05) by the 3α69 siRNA and HIF-1α mRNA to 76 + − 17 % (P not significant) of controls by the 3α70 siRNA. In reporter assays in Caki-1 cells, DP-stimulated 6 × HRE-driven luciferase activity significantly increased by 70 + − 16 % in the presence of the siRNA 3α69 and by 110 + − 55 % in the presence of the siRNA 3α70 (for both, P < 0.05, n = 6; Figure 5F ). These results indicate that HIF-3α splice variants in Hep3B and Caki-1 cells may exert inhibitory effects on HIF-1α-dependent gene activation. The modest reduction of HIF-1α and HIF-2α mRNA may have been due to non-specific effects of siRNA transfection.
Searching for endogenous HIF target genes that were regulated by HIF-3α in Caki-1 cells, we analysed RNA samples of DP-stimulated and siRNA 3α69-or 3α70-transfected cells on Affymetrix microarrays and compared them with DP-stimulated control siRNA-transfected cells (results not shown). However, despite good RNA quality, the reverse transcription and labelling process was obviously impaired by the Stealth ® siRNAs, resulting in low detection calls. A high proportion of genes not related to the hypoxia response was altered by the two HIF-3α siRNAs, which may suggest a high incidence of off-target effects. However, it cannot be excluded that the expression of genes other than HIF-1α and HIF-2α targets may be regulated by HIF-3α, since HIF-β/ ARNT, with which HIF-3α is considered to interact, is also part of other transcription-factor complexes. In the microarray, the HIF target genes Lox (lysyl oxidase), ETS1 [v-ets erythroblastosis virus E26 oncogene homologue 1 (avian)], IRS1 (insulin receptor substrate 1), TOP2B [topoisomerase (DNA) IIβ 180 kDa] and IGFBP3 (insulin-like growth factor binding protein 3) appeared in the group of transcripts slightly up-regulated by both HIF-3α siRNAs, whereas ANGPTL4, HIG2 (hypoxia-inducible protein 2) and EGLN2 [egl nine homologue 2 (Caenorhabditis elegans); also known as PHD1] were among the down-regulated genes. We investigated mRNA expression of (amongst others) Lox, ANGPTL4 and HIG2, as well as VEGF-A and PDGF-B (plateletderived growth factor β-polypeptide), because these two genes were previously associated with IPAS/HIF-3α function in Caki-1 cells by the use of qRT-PCR [8, 27] . Lox was significantly induced by HIF-3α knockdown and ANGPTL4 was reduced ( Figure 5G ). For the other genes, consistent effects of the two HIF-3α siRNAs could not be confirmed.
Immunohistochemical analyses of human RCCs reveal co-localization of HIF-3α and HIF-1α
To investigate whether HIF-3α expression correlates with HIF-1α protein accumulation in vivo, we analysed human RCCs, the majority of which are associated with inactivation of the VHL gene and thus characterized by constitutive HIF-α protein expression [17, 19] . Staining of semi-serially prepared RCC sections with anti-HIF-1α and anti-HIF-3α antibodies confirmed HIF-3α expression in 14 out of 15 kidney tumours, and comparison of the distribution patterns revealed co-localization of HIF-1α and HIF-3α ( Figure 6 and Supplementary Figure S1 at http://www.BiochemJ.org/bj/424/bj4240143add.htm). Finally, we analysed RNA from HIF-positive and HIF-negative tumours by RPA. In HIF-positive tumours, the expression of HIF-3α (both of the ODD-containing splice variants and HIF-3α4) tended to be higher than in normal kidneys, whereas the expression level in HIF-negative tumours was similar to, or even lower than, that in normal kidneys ( Figure 7 ). Altogether these observations indicate that HIF-3α may also be induced by HIF-1α in vivo. However, the lack of HIF-3α expression observed in some HIF-1α-positive tumors and in the RCC cell lines in vitro hints at the contribution of other factors to basal HIF-3α expression. 
DISCUSSION
In the present study we analysed the molecular mechanisms governing the hypoxic regulation of the human HIF-3α gene in Caki-1 renal carcinoma cells, a cell line with high endogenous HIF-3α expression. The HIF-3α splice variants identified in Caki-1 cells were simultaneously and rapidly up-regulated by hypoxia and DP. Induction kinetics and the effects of HIF-1α knockdown indicated that, for both splice variants, transcriptional activation by HIF-1α was the molecular mechanism underlying mRNA induction. In contrast, the alternatively spliced transcripts of the murine HIF-3α/IPAS gene were shown to be regulated through two complementary mechanisms: transcriptional induction and enhanced alternative splicing [10, 20] . Notably, however, total HIF-3α mRNA has been reported to be induced by systemic hypoxia in rat organs [21] as well as in A549 human lung cancer cells [22] . Three of the human HIF-3α splice variants (HIF-3α1-3) encompass an ODD with a single proline hydroxylation motif predicting destabilization by molecular oxygen. However, in the context of the full-length protein, modulation of protein stability by the HIF-3α ODD was greatly diminished [11] . Our results are in keeping with these observations and show that protein stabilization is of limited, if any, significance for the hypoxic regulation of HIF-3α.
ChIP analyses in conjunction with luciferase reporter assays served to pinpoint a functional hypoxia-responsive element in the human HIF-3α gene. The sequence of this DNA element upstream of exon 1b was ACGTC and thus slightly different from the canonical HIF binding site RCGTG. However, the transcriptional induction of the gene encoding murine IPAS was also shown to be mediated by a non-canonical novel hypoxia-responsive DNA element with no similarity to previously described HIF binding sites [10] . Inactivation of the hypoxia-responsive element by site-directed mutagenesis led to a reduction of promoter activation, confirming its functional significance. However, we cannot exclude the possibility that other cis-active elements may contribute to the hypoxic regulation of HIF-3α.
A previous study reported a decrease of HIF-3α4 mRNA in human renal carcinomas irrespective of the presence of functional pVHL [12] . In the present study, we found instead a tendency for a co-localization of HIF-3α and HIF-1α protein in human renal carcinomas, in accordance with the notion of a transcriptional induction of HIF-3α by HIF-1α. However, there were HIF-1α-positive tumours lacking immunodetectable HIF-3α. In addition, HIF-3α mRNA was not detectable in the RCC cell lines RCC4 and 786-0. Instead, early-passage hPT cells expressed considerable amounts of HIF-3α ( Figure 1G ) (comparable with Caki-1 cells) that was hypoxia-inducible in a HIF-1-dependent manner (results not shown). It should be noted that HIF-3α mRNA was downregulated after passage number 3 and was also reduced in Caki-1 cells after extensive passaging, which suggests that dedifferentiation processes may affect basal HIF-3α expression.
To date, the current knowledge on human HIF-3α function is largely confined to the variant HIF-3α4, the human orthologue of murine IPAS. In contrast with IPAS, which inhibits HIF-1α function by binding to HIF-1α, human HIF-3α4 was demonstrated to bind to both HIF-1α and ARNT [12, 23] and may thus also compete with other ARNT-dimerization partners, e.g. transcription factors involved in the xenobiotic response [2] . Therefore the modulation of a large number of genes not associated with the hypoxic response, as were detected in a microarray experiment (results not shown), do not necessarily reflect siRNA off-target effects, but may be related to functions of HIF-3α outside the HIF system.
In our attempt to identify HIF target genes whose induction was further enhanced by HIF-3α knockdown, only Lox could be confirmed, indicating that the functional significance of HIF-3α as a modulator of the hypoxic response is limited and may be target gene-and cell type-specific. Whether the unexpected reduction of hypoxic ANGPTL4 expression by HIF-3α knockdown was indeed HIF-3α-dependent remains to be clarified. As one of the HIF-1α target genes with the highest induction amplitudes [14] , ANGPTL4 is supposed to be highly sensitive towards even subtle alterations in HIF-1α transcription and translation, as they may occur during long-term exposure of cells to siRNAs.
Reports on stimulatory effects of other HIF-3α splice variants on hypoxic gene expression are rare [24, 25] . The majority of studies on HIF-3α function, which were based predominantly on overexpression experiments, point towards inhibitory effects on HIF-dependent gene regulation. Thus, along with the PHDs and the hypoxia-inducible transcriptional repressor of HIFdependent gene induction CITED2 [26] , HIF-3α may represent a further piece of a multipart system of feedback mechanisms that attenuate the hypoxic response and thereby may prevent detrimental effects of an unopposed, prolonged HIF activation. Interestingly, HIF-3α is most highly expressed in the human placenta and the myocardium [11] , tissues in which the knockout of HIF-1α or its modulators, such as PHD2 and CITED2, has severe developmental consequences. This implies that, for proper development and function of these organs, a precisely tuned control of HIF activity may be critical. In keeping with this notion, genetic deletion recently revealed the functional significance of HIF-3α and its splice variant NEPAS for the regulation of postnatal remodelling in the heart and the lung [27] . It also became evident in that study that HIF-3α splice variants do not act as global repressors of hypoxic gene induction, but may modulate specific target genes in individual cell types.
In conclusion, we identified a cell culture system suitable for the analysis of endogenous HIF-3α and demonstrated that the human HIF-3α gene is a transcriptional target of HIF-1α. The contribution of HIF-3α to gene regulation in vivo remains an important issue for further studies.
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